NIH-funded research NIH-funded research

High-throughput functional testing of MYH7 variants in heart cells

Official title: High-throughput functional characterization of MYH7 variants in genome-edited cardiomyocytes

Funded at VA Puget Sound Healthcare System · NIH-11319722 · Data updated 2026-11-12

Researchers are testing thousands of MYH7 gene variants in heart cells to better understand which changes cause disease, with the goal of helping people with hypertrophic cardiomyopathy and their families.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Puget Sound Healthcare System
NIH-funded
Lab location1 site (Seattle, United States)
Project startApril 1, 2025
Project endMarch 31, 2029
Funding year2026
NIH project number5I01BX006428-02
Project IDNIH-11319722 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with hypertrophic cardiomyopathy or a family history of HCM who carry or may carry MYH7 variants.

Less likely to help

Patients without MYH7-related HCM or variants may not directly benefit from this laboratory study.

What this research studies

This project uses genome-edited heart muscle cells derived from patient-like sources to rapidly test how different MYH7 variants affect function. By creating variant effect maps, clinicians could interpret genetic test results more clearly for individuals with suspected hypertrophic cardiomyopathy. The approach combines high-throughput screening with editing techniques to study many variants at once, aiming to translate findings into better risk assessment and management. The study is conducted in a laboratory setting with human-derived cells, focusing on understanding disease-causing changes rather than treating patients directly. Results could inform future therapies and diagnostic guidelines for HCM linked to MYH7 variants.

Why it matters

Potential benefit: If successful, this work could improve genetic interpretation for HCM, helping patients and families make informed medical decisions.

How similar studies have gone: Previous deep mutational scanning has shown promise in other genes, but applying it to MYH7 in cardiomyocytes is a novel step with potential high impact.

Where this research is happening

  • VA Puget Sound Healthcare System
    Seattle, United States
    Active

Researchers

  • Principal investigator: Yang, Kai-Chun Daniel — VA Puget Sound Healthcare System
  • Study coordinator: Yang, Kai-Chun Daniel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.